Namrata Setia to Biomarkers, Tumor
This is a "connection" page, showing publications Namrata Setia has written about Biomarkers, Tumor.
Connection Strength
1.419
-
Next-generation sequencing identifies 2 genomically distinct groups among pyloric gland adenomas. Hum Pathol. 2020 03; 97:103-111.
Score: 0.404
-
Predictive value of WHO classification for PD-L1 and Her2/Neu expression and distinct associations with protein expression based classification in gastric carcinoma. Hum Pathol. 2019 12; 94:64-70.
Score: 0.402
-
A protein and mRNA expression-based classification of gastric cancer. Mod Pathol. 2016 07; 29(7):772-84.
Score: 0.313
-
Loss of SMAD4 protein expression in gastrointestinal and extra-gastrointestinal carcinomas. Histopathology. 2019 Oct; 75(4):546-551.
Score: 0.099
-
High-throughput Protein and mRNA Expression-based Classification of Gastric Cancers Can Identify Clinically Distinct Subtypes, Concordant With Recent Molecular Classifications. Am J Surg Pathol. 2017 01; 41(1):106-115.
Score: 0.083
-
Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma. Mod Pathol. 2012 Aug; 25(8):1169-75.
Score: 0.060
-
Gastric pyloric gland adenoma: a multicentre clinicopathological study of 67 cases. Histopathology. 2018 May; 72(6):1007-1014.
Score: 0.022
-
Colorectal Carcinomas With Isolated Loss of PMS2 Staining by Immunohistochemistry. Arch Pathol Lab Med. 2018 Apr; 142(4):523-528.
Score: 0.022
-
Cutaneous neoplasms with prominent Verocay body-like structures: the so-called "rippled pattern". Am J Dermatopathol. 2011 Aug; 33(6):539-48; quiz 549-50.
Score: 0.014